Neurovations Research

Advancing innovation – Inspiring hope

Current Studies

Nature Cell Study

Evaluate the efficacy and safety of autologous stem cells in patients diagnosed with knee osteoarthritis.

ClinicalTrials Identifier: NCT04368806


Lumbosacral Radiculopathy Study

We are looking for subjects to test the safety and efficacy of an injection in treating lumbosacral radiculopathy.

Clinic Trial Identifier: NCT05614648

Study Thumbnails


Report follow-up visits, adverse events and system modifications in patients with Targeted Drug Delivery (pain pump) and Spinal Cord Stimulator.

Clinical NCT01524276


Osteoarthritis Knee  Study

Currently enrolling to test an investigational study therapy that is a type of gene therapy to potentially treat osteoarthritis (OA) of the knee.

ClinicalTrials Identifier: NCT03203330

Neurovations Research

Neurovations Research, headquartered in Napa, Ca is at the forefront of innovation in medical research. We develop evidence, through clinical research and consulting, to improve the efficiency and speed of delivery of medical devices, pharmaceuticals, and biologics to the patient.

Dr. Grigsby CEO and Founder of Neurovations
Dr. Eric Grigsby, CEO and Founder of Neurovations


Neurovations, a patient care and innovation company, was founded in 1992 by CEO Dr. Eric Grigsby. Today, Neurovations is a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience. Dr. Grigsby is deeply connected to the healthcare community through our non-profit HealthRoots Foundation and to the Napa community through Rocca Family Vineyards, a producer of award-winning wines.

Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education.